RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 ATOLL Study Shows Intravenous Enoxaparin is Associated with Better Ischemic Outcomes in Primary PCI for STEMI than UHF
JF MD Conference Express
YR 2010
FD SAGE Publications
VO 10
IS 8
SP 12
OP 13
DO 10.1177/155989771008008
UL http://mdc.sagepub.com/content/10/8/12.2.abstract
AB Although the study failed to meet its primary endpoint, results from the ATOLL study indicate that the low-molecular-weight heparin enoxaparin may provide better clinical outcomes than unfractionated heparin in ST-elevation myocardial infarction patients who are undergoing primary percutaneous coronary intervention.